...
首页> 外文期刊>International journal of computational biology and drug design >A study on druggability of MIA as a promising approach for inhibition of metastasis
【24h】

A study on druggability of MIA as a promising approach for inhibition of metastasis

机译:MIA的可药物性研究是抑制转移的有前途的方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MIA (Melanoma Inhibitory Activity) protein is over expressed in melanoma cells and binds to extracellular matrix proteins as well as to several integrins. These interactions were suggested to promote formation of metastasis. Therefore, abrogation of MIA interaction with other proteins using small molecules might show a diminishing effect on cancer cell invasion. The present study is aimed at the analysis of the integrin-binding site of MIA using molecular docking, followed by a virtual screening for drug-like compounds that show potential as putative inhibitors of MIA-integrin interaction. Results showed that at the proposed binding interface of the MIA-integrin complex, a druggable binding pocket is located. Therefore, the integrin-binding domain of MIA was used as a receptor to screen 2200 drug-like compounds. Next, we analysed the interactions of the identified hit compounds with the MIA binding pocket to find the most important features of the hit compounds.
机译:MIA(黑色素瘤抑制活性)蛋白在黑色素瘤细胞中过度表达,并与细胞外基质蛋白以及几种整联蛋白结合。这些相互作用被认为促进转移的形成。因此,使用小分子消除MIA与其他蛋白质的相互作用可能显示出对癌细胞侵袭的减弱作用。本研究旨在使用分子对接分析MIA的整联蛋白结合位点,然后进行虚拟筛选药物样化合物,这些化合物显示出可能作为MIA-整联蛋白相互作用的潜在抑制剂。结果表明,在MIA-整联蛋白复合物的拟议结合界面处,有一个可成药的结合袋。因此,MIA的整联蛋白结合域被用作筛选2200种药物样化合物的受体。接下来,我们分析了已鉴定的命中化合物与MIA结合口袋的相互作用,以发现命中化合物的最重要特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号